Expanding Market Relevance Acentus has established itself as a leading provider of continuous glucose monitors (CGMs) delivered directly to patients’ homes, indicating a strong foothold in the home healthcare and chronic condition management markets, which presents ongoing sales opportunities for related medical supplies and technology solutions.

Strategic Acquisition Recently, Acentus sold assets to Henry Schein, Inc., a major healthcare solutions provider, suggesting potential opportunities for collaborative offerings, integrated solutions, or supply chain partnerships to leverage Henry Schein’s extensive distribution channels.

Tech-Driven Service Model Acentus's proprietary technology platform and real-time referral portal demonstrate a focus on digital health solutions and operational efficiency, opening avenues for sales of complementary healthcare IT systems and enhancements aligned with telehealth trends.

Strong Revenue Base With revenues estimated between $50 million and $100 million, Acentus has a solid financial foundation that supports scaled purchasing and partnership opportunities with suppliers, device manufacturers, and health systems seeking to expand CGM and diabetes management solutions.

Focus on Patient Satisfaction Acentus’s family-owned, patient-centered approach emphasizes quality and clinician satisfaction, making the company an ideal partner for businesses aiming to align product offerings with high-quality, patient-focused healthcare delivery models.